Browsing by Author Siminelakis, S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 14 of 14
TitleAuthor(s)Issue date
Baseline cerebral oximetry values in cardiac and vascular surgery patients: a prospective observational studyBaikoussis, N. G.; Karanikolas, M.; Siminelakis, S.; Matsagas, M.; Papadopoulos, G.24-Nov-2015
Circulating matrix metalloproteinase 3 due to myocardial ischemiaSiminelakis, S.; Kotsanti, A.; Kolaitis, N.; Niokou, D.; Vlachou, I.; Dimakopoulos, G.; Papadopoulou, C.24-Nov-2015
Congenital hypopituitarism: monitoring after coronary artery bypass graftingSiminelakis, S.; Kotsanti, A.; Baikoussis, N. G.; Andrikoula, M.; Bairaktari, E.; Papadopoulos, G.24-Nov-2015
Endovascular stent-graft repair as a late secondary procedure after previous aortic graftsMatsagas, M. I.; Anagnostopoulos, C. E.; Papakostas, J. C.; DeRose, J. J.; Siminelakis, S.; Katsouras, C. S.; Toumpoulis, I. K.; Drossos, G. E.; Michalis, L. K.24-Nov-2015
Learning curves of cardiac surgery in relation to risk stratification and hospital locationAnagnostopoulos, C. E.; Siminelakis, S.; Ananiadou, O. G.; Katsaraki, A.; Drossos, G.; Katritsis, D.; Panagiotopoulos, J.; Papadopoulos, G.24-Nov-2015
Lyso platelet-activating factor accumulation in human arteries with atherosclerotic plaquesTsoukatos, D. C.; Siminelakis, S.24-Nov-2015
Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized studyPapadopoulos, G.; Sintou, E.; Siminelakis, S.; Koletsis, E.; Baikoussis, N. G.; Apostolakis, E.24-Nov-2015
Platelet-Activating Factor (Paf) Bioactivity Formation and Lyso-Paf Accumulation in Human ArteriesTsoukatos, D. C.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Brocheriou, I.; Ninio, E.; Sismanidis, S.; Siminelakis, S.24-Nov-2015
Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary arteryTsoukatos, D. C.; Brocheriou, I.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Sismanidis, S.; Ninio, E.; Siminelakis, S.24-Nov-2015
Platelet-activating factor bio-system in human arteriesTsoukatos, D. C.; Brocheriou, I.; Ninio, E.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Sismanidis, S.; Siminelakis, S.24-Nov-2015
Possible mechanism for nitric oxide and oxidative stress induced pathophysiological variance in acute myocardial infarction development - A study by a flow injection-chemiluminescence methodYao, D. C.; Vlessidis, A. G.; Evmiridis, N. P.; Siminelakis, S.; Dimitra, M.24-Nov-2015
The role of PAF-acetylhydrolase in the development of atherosclerosisTsoukatos, D. C.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussisis, S.; Brocheriou, I.; Ninio, E.; Sismanidis, S.; Siminelakis, S.24-Nov-2015
The systemic inflammatory response in coronary artery bypass grafting: what is the role of the very low ejection fraction (EF < or = 30%)?Karfis, E. A.; Papadopoulos, G.; Matsagas, M.; Pantazi, D.; Lekka, M.; Kitsiouli, I.; Siminelakis, S.; Anagnostopoulos, C.E.; Drossos, G.24-Nov-2015
The systemic inflammatory response in coronary artery bypass grafting: what is the role of the very low ejection fraction (EF <= 30%)?Karfis, E. A.; Papadopoulos, G.; Matsagas, M.; Pantazi, D.; Lekka, M.; Kitsiouli, I.; Siminelakis, S.; Anagnostopoulos, C. E.; Drossos, G.24-Nov-2015